A difficult-to-treat pleuropulmonary histoplasmosis in a patient with rheumatoid arthritis in Taiwan
- Resource Type
- article
- Authors
- Wen-Kai Chu; Un-In Wu; Tai-Fen Lee; Aristine Cheng; Kai-Hsiang Chen; Kuan-Yin Lin; Yee-Chun Chen
- Source
- Journal of Microbiology, Immunology and Infection, Vol 56, Iss 1, Pp 192-196 (2023)
- Subject
- Histoplasma capsulatum
Rheumatoid arthritis
Salvage treatment
Voriconazole
Posaconazole
Non-endemic area
Microbiology
QR1-502
- Language
- English
- ISSN
- 1684-1182
Amphotericin B and itraconazole are the primary agents for treating histoplasmosis. Newer azoles are alternatives for patients refractory to or intolerant of standard therapy. We report an 83-year-old woman with rheumatoid arthritis complicated with pleuropulmonary histoplasmosis who responded to liposomal amphotericin B, but progressed under voriconazole and posaconazole maintenance therapy.